(Investigative Ophthalmology and Visual Science. 2001;42:47-54.)
© 2001
by The Association for Research in Vision and Ophthalmology, Inc.
Structure, Function, and Regulation of Human Cystine/Glutamate Transporter in Retinal Pigment Epithelial Cells
Christy C. Bridges1,
Ramesh Kekuda2,
Haiping Wang2,
Puttur D. Prasad3,
Pooja Mehta2,
Wei Huang2,
Sylvia B. Smith1,4 and
Vadivel Ganapathy2,3
1 From the Departments of Cellular Biology and Anatomy,
2 Biochemistry and Molecular Biology,
3 Obstetrics and Gynecology, and
4 Ophthalmology, Medical College of Georgia, Augusta.
 |
Abstract
|
|---|
PURPOSE. The purpose of this investigation was to provide evidence for the
expression of the cystine/glutamate transporter
(xc-) in the human retinal pigment epithelial
cell line ARPE-19, clone the light chain of the transporter from an
ARPE-19 cell cDNA library and study its function, and investigate the
regulation of this transporter by nitric oxide (NO) in ARPE-19 cells.
METHODS. Uptake of radiolabeled cystine and glutamate was measured in ARPE-19
cells. The functional identity of xc- in these
cells was established by substrate specificity and
Na+-independence of the uptake process. The human
xc- light chain (human xCT) was cloned from an
ARPE-19 cell cDNA library. The functional identity of the cloned human
xCT was investigated by heterologous coexpression of the light chain
with the heavy chain (human 4F2hc) in HeLa cells. ARPE-19 cells were
treated with or without the NO donor
3-nitroso-N-acetylpenicillamine (SNAP) and the
expression of xc- was studied at the
functional and molecular levels.
RESULTS. ARPE-19 cells take up cystine as well as glutamate in the absence of
Na+. Substrate specificity studies indicate that although
the uptake of cystine in the absence of Na+ is mediated by
multiple amino acid transport systems including
xc-, the uptake of glutamate in the absence of
Na+ occurs exclusively via xc-.
The human xCT cloned from ARPE-19 cells is a protein of 501 amino
acids. These cells express the heavy chain 4F2hc as evidenced from
RT-PCR analysis. Coexpression of human xCT with 4F2hc in HeLa cells
leads to the induction of cystine and glutamate uptake with
characteristics similar to that of xc-. The
activity of xc- in ARPE-19 cells is
upregulated by SNAP, and the process is associated with an increase in
the expression of xCT with no detectable change in the expression of
4F2hc.
CONCLUSIONS. ARPE-19 cells express the cystine/glutamate transporter
xc- (the light chain xCT and the heavy chain
4F2hc) as is evident from functional and molecular studies. NO
upregulates this transport system and the process is associated with an
increase in xCT mRNA but with no change in 4F2hc
mRNA.
 |
Introduction
|
|---|
Glutathione plays an important role in several physiologic
processes including protection of cells against oxidative
damage.1
2
3
Oxidative damage is thought to contribute to
such diseases as age-related macular degeneration4
and
diabetic retinopathy.5
Glutathione has been detected in
high concentrations in retina and retinal pigment epithelium
(RPE).6
7
The protective effects of exogenously
administered glutathione against oxidative damage in cultured human RPE
have been reported.8
We have shown recently that
glutathione protects the reduced-folate transporter in RPE cells from
nitric oxide (NO)-induced loss of transport function.9
Glutathione is a tripeptide consisting of glutamic acid, cysteine, and
glycine. Glutamate and glycine occur at relatively high intracellular
concentrations; therefore, cysteine availability largely determines
glutathione synthesis. The extracellular concentration of cysteine is
quite low because this amino acid typically exists in the disulfide
form, cystine.10
To date, two different transport systems
have been described that mediate the uptake of cystine in mammalian
cells. They are b0,+ and
xc-.11
12
The
expression of b0,+ is limited mostly to small
intestine and kidney. b0,+ is a
Na+-independent transport system for cystine and
also for a variety of neutral and cationic amino acids. This transport
system exists as a heterodimer consisting of either rBAT (protein
related to b0,+ amino acid transport system) or
4F2hc (heavy chain of the 4F2 cell surface antigen) as the heavy chain
and b0,+ AT (b0,+ amino
acid transporter) as the light chain.13
14
15
In contrast to
b0,+, the system
xc- is expressed ubiquitously,
but at low levels, in mammalian tissues under normal
conditions.16
The expression of this system is
upregulated, however, by oxidative stress.17
18
19
20
Due to
the widespread expression and regulation by oxidative stress, the
system xc- is believed to be
the primary transport system related to the uptake of cystine into
cells for glutathione synthesis.
xc- is
Na+ - independent and mediates the entry of
cystine into cells coupled to the efflux of glutamate.21
Because of this obligatory exchange function,
xc- is called cystine/glutamate
transporter. xc- is also a
heterodimer, consisting of 4F2hc as the heavy chain and xCT
(xc- transporter) as the light
chain.22
4F2hc is a subunit common to several amino acid
transport systems including xc-
and b0,+, whereas xCT is unique to system
xc-.11
4F2hc has
been cloned from different animal species including
humans.11
In contrast, xCT has been characterized at the
molecular and functional level only in mouse.22
The purpose of the present investigation was threefold: to provide
evidence from functional studies for the expression of the transporter
xc- in the human retinal
pigment epithelial cell line ARPE-19; to clone the light chain of the
transporter, xCT, from an ARPE-19 cell cDNA library and study its
function in an heterologous expression system; and, to investigate the
regulation of xc- by NO in
ARPE-19 cells.
 |
Materials and Methods
|
|---|
Materials
[35S]-Cystine and
[3H]-glutamate were purchased from New England
Nuclear Corp. (Boston, MA). [3H]-Alanine and
[3H]-arginine were purchased from Amersham
Corp. (Piscataway, NJ). Cell culture supplies were purchased from Life
Technologies (Gaithersburg, MD). Restriction enzymes were from New
England Biolabs (Beverly, MA),
3-Nitroso-N-acetylpenicillamine (SNAP) was purchased from
Research Biochemicals International (Natick, MA). Human retinal pigment
epithelial cells (ARPE-19), a rapidly growing human RPE cell
line23
established in the laboratory of L. Hjelmeland
(University of California, Davis), were provided by R. B. Caldwell
(Medical College of Georgia, Augusta, GA). HeLa cells used for
heterologous expression were purchased from American Type Culture
Collection (Manassas, VA).
Cell Culture
ARPE-19 cells were cultured in 75 cm2
flasks with Dulbeccos modified Eagles medium: nutrient mixture F12
(DMEM:F12), supplemented with 10% fetal bovine serum, 100 U/ml
penicillin, and 100 µg/ml streptomycin. Cultures were passaged by
dissociation in 0.05% (w/v) trypsin and seeded in 24-well culture
plates (Fisher, Norcross, GA).
Uptake Measurements in ARPE-19 Cells
For uptake experiments, the culture medium was removed from RPE
cells and the cells were subsequently washed twice with uptake buffer,
which lacked Na+. The composition of the uptake
buffer was 25 mM 4-(2-hydroxyethyl)-1-piperazineethansulfonic acid
(HEPES)/Tris, 140 mM
N-methyl-D-glucamine chloride, 5.4 mM
KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, and 5 mM glucose, pH 7.5. Uptake was
initiated by adding 250 µl of uptake buffer containing radiolabeled
substrates. Uptake measurements were done with incubations for a
desired time at 37°C. At the end of the incubation, uptake was
terminated by removal of the medium by aspiration followed by three
washes with ice-cold uptake buffer without the radiolabeled substrates.
The cells were then solubilized in 0.5 ml of 1% sodium dodecylsulfate
in 0.2 N NaOH and transferred to scintillation vials for quantitation
of radioactivity. This protocol is the same as described previously
from our laboratory for the measurement of amino acid uptake in
mammalian cells expressing heterologously the cloned amino acid
transport proteins b0,+AT,13
15
LAT1,24
and LAT2.25
RT-PCR for 4F2hc mRNA and Restriction Analysis of the RT-PCR
Product
The xc system is a heterodimer consisting
of 4F2hc as the heavy chain and xCT as the light chain. To determine
whether ARPE-19 cells express 4F2hc mRNA, we used ARPE-19 cell mRNA for
RT-PCR analysis with 4F2hc-specific primers. The sense primer was
5'-GCAGAAGTGGTGGCACAC-3'corresponding to the nucleotide positions
451468 in human 4F2hc cDNA,26
and the antisense primer
was 5'-TTTTGTATGCTCCCCAGTAG AA-3'corresponding to the nucleotide
positions 10331054 in human 4F2hc cDNA. The expected size of the
RT-PCR product based on the nucleotide positions of the primer pair was
604 bp. The identity of the resulting product was established by
restriction analysis. The product was gene cleaned and digested with
BalI and PstI. The expected sizes of the
digestion products were 335 and 269 for BalI and 412 and 192
for PstI.
Construction of cDNA Library
The SuperScript plasmid system (Life Technologies) was used to
establish a unidirectional cDNA library with
poly(A)+ mRNA isolated from ARPE-19 cells.
Poly(A)+ mRNA was prepared by subjecting total
RNA twice to oligo(dT)-cellulose affinity chromatography before use in
library construction. The cDNA products with sizes greater than 1 kbp
were separated by size-fractionation and used for ligation at
SalI/NotI site in pSPORT1 vector.
cDNA Library Screening and DNA Sequencing
The ARPE-19 cell cDNA library was screened under low stringency
conditions as described previously13
15
24
25
using a
mouse xCT cDNA fragment as the probe. The probe was prepared by RT-PCR
using mouse lung mRNA and primers specific for mouse xCT. The primers
5'-TACCTGCAGGGCAATATG-3' (sense) and
5'-GGGCGTTTGTATCGAAGA-3'(antisense), corresponded to the nucleotide
positions 362379 and 15461563 in mouse xCT
cDNA22
and the expected size of the RT-PCR product was
1.2 kbp. The product was subcloned in pGEM-T vector and sequenced
for establishment of its identity. After the screening of the ARPE-19
cell cDNA library with the mouse xCT cDNA probe, positive clones were
identified, and the colonies were purified by secondary screening. Both
sense and antisense strands of the cDNA were sequenced using an
automated PerkinElmer Applied Biosystems (Framingham, MA) 377
Prism DNA sequencer. The sequence was analyzed using the GCG sequence
analysis software package, GCG version 10 (Genetics Computer Group,
Inc., Madison, WI).
Expression of the Cloned cDNA in HeLa Cells
The vaccinia virus expression system was used to functionally
characterize the cloned cDNA.13
15
24
25
The human 4F2hc
cDNA and the human xCT cDNA were cloned into pSPORT1 vector such that
the sense transcription of the cDNA is under the control of T7
promoter. The human 4F2hc cDNA was isolated from a human placental
choriocarcinoma cell (JAR) cDNA library and shown to be functional in
heterologous expression systems.13
15
24
25
The cDNAs were
transfected into HeLa cells grown in 24-well tissue culture plates
using Lipofectin, and the functional expression of the cDNAs was
analyzed 12 hours later by measuring radiolabeled amino acid uptake.
Transfection was done with human 4F2hc cDNA, human xCT cDNA or human
4F2hc cDNA plus human xCT cDNA. The transport buffer was composed of 25
mM Hepes/Tris (pH 7.5), supplemented with 140 mM
N-methyl-D-glucamine chloride, 5.4 mM
KCl, 1.8 mM CaCl2, 0.8 mM
MgSO4, and 5 mM glucose. The incubation time for
the transport measurements was 15 minutes at 37°C, after which the
uptake medium containing the radioactive substrate was aspirated off,
and the cells were washed with 2 x 2 ml of ice-cold transport
buffer. The cells were then solubilized in 0.5% SDS in 0.2 N NaOH,
transferred to vials, and radioactivity associated with the cells
quantitated by liquid scintillation spectrometry. The experiments were
repeated two to three times with independent transfections, each done
in duplicate or triplicate. Data are presented as means ± SE of
these replicate measurements.
Regulation Studies
To determine the effects of oxidative stress on the expression
of the system xc- in ARPE-19
cells, confluent cell cultures were treated with 1 mM SNAP, a NO-donor,
at 37°C for 2, 4, or 24 hours. Cells treated similarly but in the
absence of SNAP served as controls. After the treatment, uptake of
radiolabeled substrates (cystine, glutamate, alanine, and arginine)
into these cells was measured as described previously.
Semiquantitative RT-PCR Analysis of the Steady-State Levels of
mRNAs for xCT, 4F2hc and Glyceraldehyde-3-Phosphate Dehydrogenase
(GAPDH)
Confluent cultures of ARPE-19 cells were treated with or without
1 mM SNAP for 24 hours at 37°C and poly(A)+
mRNA was then prepared from these cells. RT-PCR was carried out using
primer pairs specific for human xCT, human 4F2hc, and human GAPDH. The
primers specific for human xCT were 5'-AGGGGAGTCTCCATTATCAT-3'(sense)
and 5'-AAGTAGGC CACATTTGTCAG-3' (antisense) corresponding to nucleotide
positions 373392 and 10781097 of the xCT cDNA cloned from ARPE-19
cell cDNA library. The primers specific for human 4F2hc were the same
as described previously for the analysis of 4F2hc mRNA in ARPE-19
cells. The primers specific for human GAPDH were
5'-AAGGCTGAGAACGGGAAGCTTGTCATCAAT-3' (sense) and
5'-TTCCCGTTCAGCTCAGGGATGACCTTGCCC-3' (antisense) corresponding to
nucleotide positions 241270 and 711740 in human GAPDH
cDNA.27
Each of these RT-PCR products was subcloned in
pGEM-T vector and sequenced to establish their identity. For
semiquantitative RT-PCR, PCR following reverse transcription was
carried out with varying numbers of cycles (range, 9 to 30). The
products were size-fractionated on an agarose gel and subjected to
Southern hybridization with probes specific for each of the three
products. These probes were generated by labeling the respective
subcloned RT-PCR products with [32P]dCTP. The
intensity of the hybridization signal was quantified using STORM
phosphorimaging system (Molecular Dynamics, Sunnyvale, CA). The
relationship between the intensity of the signal and the PCR cycle
number was then analyzed to determine the linear range for the PCR
product formation. The intensities of the signals within the linear
range were used for data analysis.
 |
Results
|
|---|
Functional Evidence for the Expression of
xc- System in ARPE-19 Cells
To provide evidence for the expression of system
xc- in ARPE-19 cells, the uptake of
cystine and glutamate into these cells was studied in a
Na+-free medium and the substrate specificity of
the uptake process assessed by competition experiments (Fig. 1) . The cells were found to take up [35S]cystine
and [3H]glutamate in the absence of
Na+, suggesting the presence of
Na+-independent transport mechanism(s) for these
two amino acids in these cells. Competition experiments revealed that
the Na+-independent uptake of
[35S]cystine was inhibitable by unlabeled
cystine as well as by glutamate and a variety of neutral amino acids.
In contrast, the Na+-independent uptake of
[3H]glutamate was inhibitable only by three
amino acids, namely cystine, cysteine, and unlabeled glutamate. The
substrate specificity of the transport system mediating the
Na+-independent uptake of glutamate in these
cells matches with the known substrate specificity of system
xc-. The inhibition of
Na+-independent cystine uptake by glutamate is
clear evidence for the involvement of system
xc- in cystine uptake. However,
the substrate specificity of the cystine uptake process indicates that
system xc- may not be the only
transporter mediating the uptake of cystine in these cells. These data
show that ARPE-19 cells express system
xc- and that measurement of
Na+-independent glutamate uptake rather than
cystine uptake identifies specifically the transport function of system
xc- in these cells.

View larger version (23K):
[in this window]
[in a new window]
|
Figure 1. Inhibition of Na+-independent uptake of
[35S]cystine (A) and
[3H]glutamate (B) by various amino
acids in cultured human ARPE-19 cells. Uptake of
[35S]cystine (2.5 µM) and
[3H]glutamate (2.5 µM) was measured in
confluent ARPE-19 cells in a Na+-free medium for
15 minutes at 37°C in the absence or presence of 2 mM unlabeled amino
acids (except for cystine, 0.5 mM). Results are presented as percent of
control uptake measured in the absence of unlabeled amino acids. The
values for control uptake (100%) were 46.8 ± 5.8 and 7.46 ± 0.27 pmol/106cells/15 minutes for
[35S] cystine and [3H]
glutamate, respectively. Values represent means ± SE for four
determinations from two independent experiments.
|
|
Expression of 4F2 Heavy Chain in ARPE-19 Cells
System xc- is a heterodimer
consisting of the 4F2 heavy chain (4F2hc) and the light chain xCT. If
xc- is expressed in ARPE-19
cells, 4F2hc is expected to be expressed in these cells. Therefore, to
provide evidence for the expression of 4F2hc mRNA in ARPE-19 cells,
RT-PCR was performed with ARPE-19 cell mRNA and primers specific for
human 4F2hc. An RT-PCR product of expected size (604 bp) was obtained
from the mRNA, demonstrating the expression of 4F2hc mRNA in these
cells (Fig. 2)
. The molecular identity of the resultant product was confirmed by
restriction analysis with two different restriction enzymes
(BalI and PstI). Both enzymes
yielded restriction fragments of expected size from the RT-PCR product
(Fig. 2)
.

View larger version (34K):
[in this window]
[in a new window]
|
Figure 2. RT-PCR and restriction analysis of 4F2hc mRNA in human ARPE-19 cells.
Poly(A)+ RNA from ARPE-19 cells was used for RT-PCR with
human 4F2hc-specific primers. The expected size of the RT-PCR product
(uncut), predicted from the positions of the primers, is 604 bp. The
RT-PCR product was gene-cleaned and then used for restriction analysis
with BalI and PstI. DNA standards (100
bp12.2 kbp) were run on the gel in parallel to determine the size of
the RT-PCR product and restriction fragments. The expected sizes of the
digestion products are 335 and 269 bp for BalI and 412
and 192 bp for PstI.
|
|
Primary Structure and Functional Characteristics of Human xCT
Cloned from ARPE-19 Cells
The light chain of system
xc-, called xCT, has been cloned
from mouse macrophage and its interaction with 4F2hc to form a
transport-competent heterodimer has been demonstrated.22
A
GenBank database search revealed that the human homolog of xCT has been
cloned and characterized at the structural level (GenBank accession no.
AB026891). But, there is no information available in the literature on
the functional characteristics of human xCT. To provide evidence for
the expression of xCT mRNA in these cells and to elucidate the
functional characteristics of the xCT protein, we cloned the
full-length xCT cDNA from these cells. This was accomplished by
constructing an ARPE-19 cell cDNA library followed by screening of the
library with a mouse xCT-specific cDNA fragment as the probe. The human
xCT cDNA isolated from the library is 2482 bp-long with a poly(A) tail
(GenBank accession no. AF252872). This cDNA has a coding region of 1506
bp (including the termination codon), flanked by a 231 bp-long
5'-untranslated region and a 746 bp-long 3'-untranslated region. The
cDNA cloned from ARPE-19 cells is considerably longer than the cDNA
reported in the GenBank, which is 1852 bp-long. The difference between
the two cDNAs is in the 3'-untranslated region. Because both cDNAs
possess a poly(A) tail, the difference in the 3'-untranslated region
arises most likely from alternative splicing. Both cDNAs however code
for an identical protein of 501 amino acids with 12 putative
transmembrane domains. The amino acid sequence of human xCT is highly
homologous to that of mouse xCT with 89% identity and 96% similarity
(Fig. 3)
. One interesting difference between the human and mouse xCT proteins
however is that human xCT contains a potential site for
N-linked glycosylation (Asn-314) in the extracellular loop
between transmembrane domains 7 and 8, whereas mouse xCT does not
possess any potential site for N-linked glycosylation. This
raises the possibility that human xCT, but not mouse xCT, may be a
glycoprotein.

View larger version (91K):
[in this window]
[in a new window]
|
Figure 3. Amino acid sequence of human xCT cloned from ARPE-19 cells. The
sequence of human xCT (hxCT) is aligned with the known sequence of
mouse xCT (mxCT). Shaded boxes denote identical regions
of the mouse and human xCT. Putative transmembrane domains are
underlined and the N-linked glycosylation
site in hxCT is indicated (Asn-314).
|
|
Functional characteristics of the human xCT cloned from ARPE-19 cells
were analyzed by heterologous expression of the cDNA in HeLa cells.
Human xCT cDNA was expressed either alone or with human 4F2hc cDNA and
the transport function was monitored by measuring the uptake of cystine
and glutamate in the absence of Na+ (Fig. 4)
. The uptake of these amino acids in HeLa cells transfected with vector
alone was similar to the uptake in HeLa cells expressing 4F2hc or xCT
independently. This shows that neither 4F2hc nor xCT, when expressed
alone, is capable of amino acid transport. However, when 4F2hc and xCT
were coexpressed, the uptake of cystine and glutamate increased
several-fold. These results show that the 4F2hc/xCT heteromeric complex
is capable of mediating Na+-independent uptake of
cystine and glutamate.

View larger version (13K):
[in this window]
[in a new window]
|
Figure 4. Transport function of the 4F2hc/xCT complex in HeLa cells. Cells were
transfected with pSPORT vector (P + P), h4F2hc cDNA (P + F), hxCT cDNA
(P + X) or hxCT cDNA plus h4F2hc cDNA (X + F). DNA content during
transfection was kept constant by the addition of the pSPORT vector (P)
as required. Expression of the transfected cDNAs was carried out by the
vaccinia virus expression technique. Uptake of
[35S]cystine (25 µM) and [3H]glutamate
(25 µM) was measured in these cells in a Na+-free medium
for 15 minutes at 37°C. Values are means ± SE for six
determinations done with two independent transfections.
|
|
The substrate specificity of the transport process associated with the
4F2hc/xCT complex was investigated by assessing the ability of various
amino acids to compete with [3H]glutamate for
Na+-independent uptake into HeLa cells
coexpressing human 4F2hc and human xCT heterologously (Fig. 5A
). Unlabeled glutamate and cystine were the most potent inhibitors of
[3H]glutamate uptake mediated by the
heteromeric complex. Cysteine and aspartate also showed appreciable
inhibition. Other amino acids including various neutral amino acids and
the cationic amino acid arginine exhibited small or no inhibitory
potency. The uptake of glutamate mediated by the 4F2hc/xCT complex was
saturable over a glutamate concentration range of 0.025 to 2 mM (Fig. 5B)
. The uptake data conformed to the MichaelisMenten kinetics
describing a single saturable transport system. The apparent
MichaelisMenten constant (Kt) and the maximal
velocity (Vmax) for the uptake process were 48
µM ± 4 µM and 25.5 ± 0.4 nmol/106
cells/15 minutes, respectively.

View larger version (21K):
[in this window]
[in a new window]
|
Figure 5. Substrate specificity (A) and saturation kinetics
(B) of the transport function induced by the h4F2hc/hxCT
complex in HeLa cells. Cells were transfected with either pSPORT alone
or h4F2hc cDNA plus hxCT cDNA and the transfected cDNAs were expressed
by the vaccinia virus expression technique. For the substrate
specificity studies, uptake of [3H]glutamate
(25 µM) in these cells was measured in a
Na+-free medium for 15 minutes at 37°C in the
absence or presence of 5 mM various amino acids. Data represent
only the h4F2hc/hxCT complex-specific uptake (i.e., uptake in cells
transfected with h4F2hc cDNA plus hxCT cDNA minus uptake in cells
transfected with vector alone) and are given as percent of control
uptake measured in the absence of unlabeled amino acids (100% =
11.0 ± 0.5 nmol/106 cells/15 min). Values
are means ± SE for six determinations from two independent
transfections. For saturation kinetics studies, uptake of glutamate was
measured in a Na+-free medium for 15 minutes at
37°C over a glutamate concentration range of 0.025 to 2 mM. Data
represent only the h4F2hc/hxCT complex-specific uptake. Values are
means ± SE for six determinations from two separate
transfections. Inset: EadieHofstee plot.
|
|
Regulation of Expression of System
xc- by NO in ARPE-19 Cells
The regulation of system
xc- function by NO in ARPE-19
cells was investigated at the functional level as well as at the
molecular level. Treatment of confluent cultures of ARPE-19 cells with
SNAP, a NO donor, for 24 hours increased the
Na+-independent uptake of cystine and glutamate
(Fig. 6)
. This increase was not observed when the treatment time was 1 hour or
6 hours. The stimulatory effect of SNAP on the uptake of cystine and
glutamate was specific because under identical conditions the treatment
did not increase the Na+-independent uptake of
two other amino acids, namely alanine and arginine (data not shown).
System xc- does not accept
alanine or arginine as substrates. In contrast, the
Na+-independent glutamate uptake is entirely due
to the activity of system xc-.
These results therefore show that NO induces the activity of system
xc- specifically. We then
analyzed the kinetics of system
xc- activity in control cells
and in cells treated with SNAP (Fig. 7)
. The transport function of system
xc- was monitored by measuring
the Na+-independent uptake of glutamate. The
kinetic studies with glutamate as the substrate showed that the
increase in the transport activity of system
xc- observed in SNAP-treated
ARPE-19 cells compared to control cells was primarily associated with
an increase in the maximal velocity of the transporter with no
significant change in the substrate affinity. The maximal velocity of
glutamate uptake was 2.7-fold greater in SNAP-treated cells than in
control cells (32.3 ± 0.4 vs. 11.8 ± 0.7 nmol/mg of
protein/30 min). The MichaelisMenten constant for glutamate remained
almost the same in SNAP-treated cells and in control cells (221 ±
18 µM vs. 275 ± 23 µM).

View larger version (34K):
[in this window]
[in a new window]
|
Figure 6. Upregulation of the Na+-independent uptake of cystine
(A) and glutamate (B) in ARPE-19 cells by SNAP.
Confluent cells were treated in the absence or presence of 1 mM SNAP at
37°C for 1, 6, or 24 hours. Uptake of
[35S]cystine (2.5 µM) and
[3H]glutamate (0.2 µM) was measured in these
cells for 30 minutes at 37°C in a Na+-free
medium. Values are means ± SE for six determinations from two
independent experiments.
|
|

View larger version (12K):
[in this window]
[in a new window]
|
Figure 7. Kinetics of glutamate uptake in control ( ) and SNAP-treated ()
ARPE-19 cells. Confluent cells were treated with or without 1 mM SNAP
for 24 hours at 37°C. Uptake of glutamate was measured in these cells
for 30 minutes at 37°C in a Na+-free medium over a
glutamate concentration range of 25 µM to 1000 µM. Values are
means ± SE for six determinations from two independent
experiments. Results are presented as EadieHofstee plots (V,
glutamate uptake in nmol/mg of protein/30 min; S, glutamate
concentrationin µM).
|
|
Next examined was the influence of cycloheximide (an inhibitor of
translation) and actinomycin D (an inhibitor of transcription) on
SNAP-induced increase in xc-
activity. Both compounds decreased the stimulatory effect of SNAP to a
significant extent. The stimulation of
xc- activity by SNAP in the
absence of inhibitors was 2.7-fold ± 0.1-fold. This value
decreased to 2.0 ± 0.1 in the presence of cycloheximide
(75µg/ml) and 1.3 ± 0.1 in the presence of actinomycin D (7.5
µg/ml). These data suggest that the stimulatory effect of SNAP on
xc- activity involves de novo
synthesis of xc-.
The influence of the SNAP treatment was studied on the steady-state
levels of mRNA transcripts specific for the two protein components of
system xc-, namely 4F2hc and
xCT. mRNA samples isolated from control and SNAP-treated ARPE-19 cells
were used for semiquantitative RT-PCR for the determination of the
levels of mRNA transcripts. As an internal control, the steady-state
levels of the glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was
determined in the mRNA samples in parallel. The results of these
experiments showed that treatment with SNAP did not alter the
steady-state levels of 4F2hc mRNA (Fig. 8)
. The small increase in 4F2hc mRNA seen in SNAP-treated cells versus
control cells was similar to the increase in the steady-state levels of
GAPDH mRNA. In contrast, the steady-state levels of xCT mRNA increased
markedly in SNAP-treated cells compared to control cells and this
increase was much higher than observed in the case of 4F2hc mRNA and
GAPDH mRNA. These results demonstrate that the SNAP-induced increase in
the transport activity of system
xc- is associated with an
increase in the expression of xCT with no significant change in the
expression of 4F2hc.

View larger version (29K):
[in this window]
[in a new window]
|
Figure 8. Analysis of steady-state levels of mRNA for xCT, 4F2hc, and
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) in control (-
SNAP) and SNAP-treated (+ SNAP) ARPE-19 cells. Confluent cells were
treated with or without 1 mM SNAP for 24 hours at 37°C.
Poly(A)+ RNA was then isolated from these cells and used
for semiquantitative RT-PCR. Primer pairs specific for human xCT mRNA,
human 4F2hc mRNA and human GAPDH mRNA were used. RT-PCR was done with a
wide range of PCR cycles (930). The resultant products were run on a
gel and then subjected to Southern hybridization with
32P-labeled cDNA probes specific for xCT, 4F2hc, and GAPDH.
The hybridization signals were quantified using the STORM
Phosphorimaging System, and the intensities that were in the linear
range with the PCR cycle number were used for analysis.
Left: representative Southern hybridization signal.
Right: band intensity in SNAP-treated cells relative to
band intensity in control cells.
|
|
 |
Discussion
|
|---|
As the cellular uptake of cystine is responsible for the
availability of cysteine for intracellular glutathione synthesis,
studies of the expression and regulation of the transport systems that
mediate this uptake process in ocular tissues are of physiological and
clinical significance. The eye is exposed constantly to irradiation;
therefore, the ocular tissues have an extraordinary need for
antioxidant protection. Glutathione in these tissues may serve to
provide this protection. The present investigation was undertaken to
examine the expression of the amino acid transport system
xc- in RPE cells because system
xc- plays a primary role in
supplying cysteine for glutathione synthesis, and this system is
regulated by oxidative stress.17
18
19
20
This investigation
has provided clear evidence at the functional and molecular level for
the expression of system xc- in
these cells and also for the regulation of its expression by NO.
System xc- is a
Na+-independent exchanger for cystine and
glutamate and couples the influx of cystine to the efflux of glutamate
in cells. This system can be studied by monitoring the
Na+-independent uptake of radiolabeled cystine or
glutamate, which occurs in exchange with intracellular glutamate.
Functional studies in ARPE-19 cells using this approach demonstrate
that system xc- is expressed in
these cells. In addition to system
xc-, other transport systems
such as b0,+ may also be present in these cells
that contribute to the influx of cystine. However, when glutamate is
used as the substrate instead of cystine, the uptake appears to be
mediated exclusively by system
xc-.
System xc- functions as a
heterodimer consisting of 4F2hc and xCT. Evidence is shown here for the
expression of both of these components in ARPE-19 cells. The presence
of 4F2hc mRNA in these cells was established by RT-PCR. The presence of
xCT mRNA was shown by isolation of a full-length xCT cDNA from an
ARPE-19 cell cDNA library. Even though the nucleotide sequence of human
xCT cDNA has been deposited in the GenBank database by other
investigators (accession number AB026891), no information is available
on the functional identity of the clone. In this article, evidence is
provided for the first time for the transport function of the cloned
human xCT. This was accomplished by using an heterologous expression
system in which human 4F2hc and human xCT were coexpressed. If
expressed independently, neither of these proteins exhibits detectable
transport function. However, when coexpressed, the 4F2hc/xCT
heteromeric complex mediates the transport of cystine and glutamate.
The functional characteristics of the transport process associated with
the heteromeric complex are similar to those of system
xc-. It is interesting that the
substrate affinity of the heterologously expressed system
xc- is significantly different
from that of the constitutively expressed system
xc- (kt
value: 48 ± 4 vs. 221 ± 18 µM). This difference is likely
due to the different cell types used in the determination of the
substrate affinity. The heterologously expressed system
xc- was studied in HeLa cells,
whereas the constitutively expressed system
xc- was studied in ARPE-19
cells. The kinetic parameters of a transport system may differ
significantly in different cell types, influenced by the cell
type-specific differences in posttranslational modification such as
glycosylation and in the microenvironment of the transport protein in
the membrane.
After establishing the expression of system
xc- in ARPE-19 cells at the
functional and molecular level, we investigated the regulation of the
expression of this transport system by NO. Exposure of the cells to
SNAP, an NO donor, for 24 hours leads to an increase in the
Na+-independent uptake of cystine and glutamate
in these cells. This stimulatory effect is not seen if the exposure
time is less than 6 hours. The increase in system
xc- activity resulting from
NO-exposure is accompanied by an increase in the maximal velocity of
the transport process. The substrate affinity of the process is not
altered. These results, together with the need for a long treatment
period to elicit the observed effect, suggest that the increase in
transport function is most likely due to an increase in the transporter
density in the cell plasma membrane. This is supported by the findings
that cycloheximide (an inhibitor of translation) and actinomycin D (an
inhibitor of transcription) attenuate the stimulatory effect of SNAP to
a significant extent. As system
xc- is a heterodimer consisting
of 4F2hc as the heavy chain and xCT as the light chain, the question
arises as to which of these two proteins is expressed at higher levels
as a result of exposure to NO. We addressed this question by
quantifying the steady-state levels of 4F2hc mRNA and xCT mRNA in
control and NO-treated cells. These studies have shown that NO
increases only the steady-state levels of xCT mRNA. The levels of 4F2hc
mRNA are not influenced by NO. The specific stimulatory effect of NO on
xCT expression suggests that the levels of xCT constitute the
rate-limiting factor in the formation of the transport-competent
4F2hc/xCT heteromeric complex. Furthermore, 4F2hc is not unique to
system xc- because this protein
is also a component of several other amino acid transport systems such
as systems L, y+L, and
b0,+. Therefore, the stimulatory influence of NO
on the expression of only xCT confers the specificity of NO action on
system xc-.
The stimulation of xc-
expression by NO has physiological relevance. Oxidative stress is
expected to deplete the cellular levels of antioxidants such as
glutathione. An increase in the expression of system
xc- following exposure to NO
may be a physiologic response of the cell to oxidative stress as an
attempt to increase the cellular levels of cysteine for glutathione
synthesis. Although studies from other laboratories have demonstrated
the stimulatory effect of oxidative stress on system
xc- in different cell
types,17
18
19
20
for the first time here, the basis for the
stimulatory effect at the molecular level is described. Several
diseases in humans are associated with oxidative stress. These include
diabetes, bacterial infection, AIDS, and several neurodegenerative
disorders. It is speculated that the expression of system
xc- may be significantly
upregulated under these pathologic conditions in an attempt to increase
glutathione levels as an antioxidant protective mechanism against the
oxidative stress.
 |
Footnotes
|
|---|
Supported by funding from Research to Prevent Blindness, Fight for Sight Division of Prevent Blindness America, and National Institutes of Health Grants EY13089 and EY12830.
Submitted for publication May 26, 2000; revised September 18, 2000; accepted September 29, 2000.
Commercial relationships policy: N.
Corresponding author: Vadivel Ganapathy, Department of Biochemistry and Molecular Biology, Medical College of Georgia, Augusta, GA 30912. vganapat{at}mail.mcg.edu
 |
References
|
|---|
-
Hayes, JD, McLellan, LI (1999) Glutathione and glutathione-dependent enzymes represent a co-ordinately regulated defence against oxidative stress Free Radic Res 31,273-300[Medline][Order article via Infotrieve]
-
Hall, HG (1999) The role of glutathione in the regulation of apoptosis Eur J Clin Invest 29,238-245[Medline][Order article via Infotrieve]
-
Janaky, R, Ogita, K, Pasqualotto, BA, et al (1999) Glutathione and signal transduction in the mammalian CNS J Neurochem 73,889-902[Medline][Order article via Infotrieve]
-
Winkler, BS, Boulton, ME, Gottsch, JD, Sternberg, P. (1999) Oxidative damage and age-related macular degeneration Mol Vis 5,32[Medline][Order article via Infotrieve]
-
Grattagliano, I, Vendemiale, G, Boscia, F, et al (1998) Oxidative retinal products and ocular damages in diabetic patients Free Radic Biol Med 25,369-372[Medline][Order article via Infotrieve]
-
Saxena, M, Singhal, SS, Awasthi, YC (1992) A specific, sensitive, and rapid method for the determination of glutathione and its application in ocular tissues Exp Eye Res 55,461-468[Medline][Order article via Infotrieve]
-
Huster, D, Hjelle, OP, Haug, FM, et al (1998) Subcellular compartmentation of glutathione and glutathione precursors. A high resolution immunogold analysis of the outer retina of guinea pig Anat Embryol 198,277-287[Medline][Order article via Infotrieve]
-
Sternberg, P, Jr, Davidson, PC, Jones, DP, et al (1993) Protection of retinal pigment epithelium from oxidative injury by glutathione and precursors Invest Ophthalmol Vis Sci 34,3661-3668[Abstract/Free Full Text]
-
Smith, SB, Huang, W, Chancy, C, Ganapathy, V. (1999) Regulation of the reduced-folate transporter by nitric oxide in cultured human retinal pigment epithelial cells Biochem Biophys Res Commun 257,279-283[Medline][Order article via Infotrieve]
-
Bannai, S. (1984) Transport of cystine and cysteine in mammalian cells Biochim Biophys Acta 779,289-306[Medline][Order article via Infotrieve]
-
Palacin, M, Estevez, R, Bertran, J, Zorzano, A. (1998) Molecular biology of mammalian plasma membrane amino acid transporters Physiol Rev 78,969-1054[Abstract/Free Full Text]
-
Ganapathy, V, Leibach, FH (1999) Protein digestion and assimilation Yamada, T eds. Textbook of Gastroenterology ,456-467 Lippincott Williams & Wilkins Philadelphia, PA.
-
Rajan, DP, Huang, W, Kekuda, R, et al (2000) Differential influence of the 4F2 heavy chain and the protein related to b0,+ amino acid transport on substrate affinity of the heteromeric b0,+ amino acid transporter J. Biol. Chem. 275,14331-14335[Abstract/Free Full Text]
-
. International Cystinuria Consortium (1999) Non-type I cystinuria caused by mutations in SLC7A9, encoding a subunit (b0,+ AT) of rBAT Nat Genet 23,52-57[Medline][Order article via Infotrieve]
-
Rajan, DP, Kekuda, R, Huang, W, et al (1999) Cloning and expression of a b0,+-like amino acid transporter functioning as a heterodimer with 4F2hc instead of rBAT. A new candidate gene for cystinuria J Biol Chem 274,29005-29010[Abstract/Free Full Text]
-
Guidotti, GG, Gazzola, GC (1992) Amino acid transporters: systematic approach and principles of control Kilberg, MS Haussinger, D eds. Mammalian Amino Acid Transport. Mechanisms and Control ,3-30 Plenum New York.
-
Bannai, S, Sato, H, Ishii, T, Sugita, Y. (1989) Induction of cystine transport activity in human fibroblasts by oxygen J Biol Chem 264,18480-18484[Abstract/Free Full Text]
-
Li, H, Marshall, ZM, Whorton, AR (1999) Stimulation of cystine uptake by nitric oxide: regulation of endothelial cell glutathione levels Am J Physiol 276,C803-C811[Abstract/Free Full Text]
-
Miura, K, Ishii, T, Sugita, Y, Bannai, S. (1992) Cystine uptake and glutathione level in endothelial cells exposed to oxidative stress Am J Physiol 262,C50-C58[Abstract/Free Full Text]
-
Sato, H, Takenaka, Y, Fujiwara, K, et al (1995) Increase in cystine transport activity and glutathione level in mouse peritoneal macrophages exposed to oxidized low-density lipoprotein Biochem Biophys Res Commun 215,154-159[Medline][Order article via Infotrieve]
-
Bannai, S. (1986) Exchange of cystine and glutamate across plasma membrane of human fibroblasts J Biol Chem 261,2256-2263[Abstract/Free Full Text]
-
Sato, H, Tamba, M, Ishii, T, Bannai, S. (1999) Cloning and expression of a plasma membrane cystine/glutamate exchange transporter composed of two distinct proteins J Biol Chem 274,11455-11458[Abstract/Free Full Text]
-
Dunn, KC, Aotaki-Keen, AE, Putkey, FR, Hjelmeland, LM (1996) ARPE-19, a human retinal pigment epithelial cell line with differentiated properties Exp Eye Res 62,155-169[Medline][Order article via Infotrieve]
-
Prasad, PD, Wang, H, Huang, W, et al (1999) Human LAT1, a subunit of system L amino acid transporter: molecular cloning and transport function Biochem Biophys Res Commun 255,283-288[Medline][Order article via Infotrieve]
-
Rajan, DP, Kekuda, R, Huang, W, et al (2000) Cloning and functional characterization of a Na(+)-independent, broad-specific neutral amino acid transporter from mammalian intestine Biochim Biophys Acta 1463,6-14[Medline][Order article via Infotrieve]
-
Quackenbush, E, Clabby, M, Gottesdiener, KM, et al (1987) Molecular cloning of complementary DNAs encoding the heavy chain of the human 4F2 cell-surface antigen: a type II membrane glycoprotein involved in normal and neoplastic cell growth Proc Natl Acad Sci USA 84,6526-6530[Abstract/Free Full Text]
-
Tokunaga, K, Nakamura, Y, Sakata, K, et al (1987) Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers Cancer Res 47,5616-5619[Abstract/Free Full Text]
This article has been cited by other articles:

|
 |

|
 |
 
M. M. Lall, J. Ferrell, S. Nagar, L. N. Fleisher, and M. C. McGahan
Iron Regulates L-Cystine Uptake and Glutathione Levels in Lens Epithelial and Retinal Pigment Epithelial Cells by Its Effect on Cytosolic Aconitase
Invest. Ophthalmol. Vis. Sci.,
January 1, 2008;
49(1):
310 - 319.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. C. McGahan, J. Harned, M. Mukunnemkeril, M. Goralska, L. Fleisher, and J. B. Ferrell
Iron alters glutamate secretion by regulating cytosolic aconitase activity
Am J Physiol Cell Physiol,
May 1, 2005;
288(5):
C1117 - C1124.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Bridges, H. Hu, S. Miyauchi, U. N. Siddaramappa, M. E. Ganapathy, L. Ignatowicz, D. M. Maddox, S. B. Smith, and V. Ganapathy
Induction of Cystine-Glutamate Transporter xc- by Human Immunodeficiency Virus Type 1 Transactivator Protein Tat in Retinal Pigment Epithelium
Invest. Ophthalmol. Vis. Sci.,
September 1, 2004;
45(9):
2906 - 2914.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Bridges, C. Bauch, F. Verrey, and R. K. Zalups
Mercuric Conjugates of Cysteine Are Transported by the Amino Acid Transporter System b0,+: Implications of Molecular Mimicry
J. Am. Soc. Nephrol.,
March 1, 2004;
15(3):
663 - 673.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. J. Gukasyan, R. Kannan, V. H. L. Lee, and K.-J. Kim
Regulation of L-Cystine Transport and Intracellular GSH Level by a Nitric Oxide Donor in Primary Cultured Rabbit Conjunctival Epithelial Cell Layers
Invest. Ophthalmol. Vis. Sci.,
March 1, 2003;
44(3):
1202 - 1210.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. E. Mann, D. L. Yudilevich, and L. Sobrevia
Regulation of Amino Acid and Glucose Transporters in Endothelial and Smooth Muscle Cells
Physiol Rev,
January 1, 2003;
83(1):
183 - 252.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Baker, Z.-X. Xi, H. Shen, C. J. Swanson, and P. W. Kalivas
The Origin and Neuronal Function of In Vivo Nonsynaptic Glutamate
J. Neurosci.,
October 15, 2002;
22(20):
9134 - 9141.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-i. Hosoya, M. Tomi, S. Ohtsuki, H. Takanaga, S. Saeki, Y. Kanai, H. Endou, M. Naito, T. Tsuruo, and T. Terasaki
Enhancement of L-Cystine Transport Activity and Its Relation to xCT Gene Induction at the Blood-Brain Barrier by Diethyl Maleate Treatment
J. Pharmacol. Exp. Ther.,
July 1, 2002;
302(1):
225 - 231.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Tomi, K.-i. Hosoya, H. Takanaga, S. Ohtsuki, and T. Terasaki
Induction of xCT Gene Expression and L-Cystine Transport Activity by Diethyl Maleate at the Inner Blood-Retinal Barrier
Invest. Ophthalmol. Vis. Sci.,
March 1, 2002;
43(3):
774 - 779.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. C. Bridges, M. S. Ola, P. D. Prasad, A. El-Sherbeny, V. Ganapathy, and S. B. Smith
Regulation of taurine transporter expression by NO in cultured human retinal pigment epithelial cells
Am J Physiol Cell Physiol,
December 1, 2001;
281(6):
C1825 - C1836.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Chillaron, R. Roca, A. Valencia, A. Zorzano, and M. Palacin
Heteromeric amino acid transporters: biochemistry, genetics, and physiology
Am J Physiol Renal Physiol,
December 1, 2001;
281(6):
F995 - F1018.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. A. Wagner, F. Lang, and S. Broer
Function and structure of heterodimeric amino acid transporters
Am J Physiol Cell Physiol,
October 1, 2001;
281(4):
C1077 - C1093.
[Abstract]
[Full Text]
[PDF]
|
 |
|